Screening compound: InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3

Screening compound: InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3
Screening compound: InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C169-0158

Molecular Formula

C21H20N4O2 (C21 H20 N4 O2)

Compound Name

4-{3-[(2,6-dimethylphenyl)amino]imidazo[1,2-a]pyrazin-2-yl}-2-methoxyphenol

IUPAC name

4-{3-[(26-dimethylphenyl)amino]imidazo[12-a]pyrazin-2-yl}-2-methoxyphenol

SMILES

Cc1cccc(C)c1Nc1c(-c(cc2)cc(OC)c2O)nc2n1ccnc2

InChI

InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3

InChI Key

MZNYWMDAODWBCD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08682343

InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Antiviral Annotated Library (21441 compounds)

CNS Targets (44014 compounds)

Human Proteases Annotated Library (2868 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3?
Check Price and Availability of InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H20N4O2/c1-13-5-4-6-14(2)19(13)24-21-20(23-18-12-22-9-10-25(18)21)15-7-8-16(26)17(11-15)27-3/h4-12,24,26H,1-3H3 available by request